Article
Are Skinny Labels Getting Heavier For Generics? Key Takeaways From Hikma v. Amarin, The Supreme Court's First Patent Case Since 2023
As prescription drug prices continue to soar in the United States, the Supreme Court recently heard the highly anticipated oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
Crowell & Moring LLP